Effect of cancer cachexia on the outcomes of first-line chemotherapy in pancreatic cancer: A claims database study

被引:0
|
作者
Furuse, Junji [1 ]
Osugi, Fumihiko [2 ]
Machii, Koji [2 ]
Niibe, Koji [2 ]
Endo, Toshimitsu [2 ]
机构
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[2] Ono Pharmaceut Co Ltd, Ono, Hokkaido, Japan
关键词
D O I
10.1016/j.annonc.2023.09.308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MO61-3
引用
收藏
页码:S1435 / S1435
页数:1
相关论文
共 50 条
  • [41] Update on first-line and relapse chemotherapy for testicular cancer
    Lorch, A.
    Albers, P.
    UROLOGE, 2013, 52 (11): : 1547 - +
  • [42] Intraarterial chemotherapy as the first-line therapy in penile cancer
    Chiang, P-H
    Chen, C-H
    Shen, Y-C
    BRITISH JOURNAL OF CANCER, 2014, 111 (06) : 1089 - 1094
  • [44] Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy
    Rittberg, Rebekah
    Zhang, Hanbo
    Lambert, Pascal
    Kudlovich, Robert
    Kim, Christina A.
    Dawe, David E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (01) : 112 - 117
  • [45] Optimizing first-line chemotherapy for metastatic colorectal cancer
    Adams, Richard A.
    COLORECTAL CANCER, 2012, 1 (03) : 241 - 253
  • [46] The impact of first-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective study
    Maratta, M.
    Chiaravalli, M.
    Bensi, M.
    Di Stefano, B.
    Ribelli, M.
    Barone, D.
    Gurreri, E.
    Monaca, F.
    Cutigni, C.
    Bagala, C.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S122 - S122
  • [47] Effect of advanced age, elevated bilirubin, and disease extent on outcomes of unresectable pancreatic cancer (UPC) patients receiving first-line chemotherapy: A population-based study
    Cherniawsky, Hannah Marie
    Wang, Ying
    Ghosh, Sunita
    Cheung, Winson Y.
    Ho, Maria Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [48] First-line chemotherapy with gemcitabine in advanced pancreatic cancer: a retrospective single-center analysis
    Magalhaes, H.
    Cassiano Neves, M.
    Fontes e Sousa, M.
    Machado, M.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Luis, M.
    Sales, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [49] NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
    Nichetti, Federico
    Rota, Simone
    Ambrosini, Paolo
    Pircher, Chiara
    Gusmaroli, Eleonora
    Busset, Michele Droz Dit
    Pusceddu, Sara
    Sposito, Carlo
    Coppa, Jorgelina
    Morano, Federica
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    Mariani, Luigi
    Mazzaferro, Vincenzo
    de Braud, Filippo
    Niger, Monica
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [50] The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer
    Takeda, Tsuyoshi
    Sasaki, Takashi
    Mie, Takafumi
    Furukawa, Takaaki
    Yamada, Yuto
    Kasuga, Akiyoshi
    Matsuyama, Masato
    Ozaka, Masato
    Sasahira, Naoki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) : 728 - 736